Clinical trial
Induction of Immunogenicity With Different Doses of Grass MATA in Subjects…
NCT00104377 · Allergy Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00104377 |
|---|---|
| Title | Induction of Immunogenicity With Different Doses of Grass MATA in Subjects Allergic to Grass and Rye Pollen |
| Official title | A Multicenter, Single-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Induction of Immunogenicity With Different Doses of Grass MATA in Subjects Allergic to Grass and Rye Pollen |
| Lead sponsor | Allergy Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Type I Hypersensitivity |
| Intervention type | Biological |
| Interventions | Grass MATA MPL |
| Enrollment | 70 |
| Start date | Mar 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Mar 1, 2005 |
| Last update posted | Jun 17, 2010 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: